Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety

The Veterinary Record
Antonio J VillatoroJosé Becerra

Abstract

Canine atopic dermatitis (AD) is a common skin disease with a 10-15 per cent prevalence. Current treatments vary in their efficacy and safety. The immunomodulatory properties of mesenchymal stem cells (MSCs) make them a promising alternative treatment. The aim of this study was to evaluate the therapeutic efficacy and safety of allogeneic canine adipose MSCs (cAd-MSCs) in dogs with refractory AD. Twenty-six dogs, suffering from AD for at least 12 months, not responding to conventional therapy, received an intravenous dose of 1.5×106 cAd-MSCs/kg bodyweight. Clinical signs, haematological and biochemistry profiles, and AD severity were assessed in a six-month follow-up using a validated scoring system (Canine Atopic Dermatitis Extent and Severity Index, version 4 (CADESI-04)). The degree of pruritus was quantified using a validated visual analogue scale, and also owner's global assessment of treatment efficacy. Twenty-two animals completed the study. Pruritus and CADESI-04 scores decreased significantly after one week or month of treatment, respectively, and remained stable for six months. Owner's global assessment score was 2.15±1.15 for all the animals in the study. In conclusion, systemic administration of allogeneic cAd-MSCs ...Continue Reading

References

Apr 19, 2002·Annals of the New York Academy of Sciences·Richard T Born, Christopher C Pack
Jun 20, 2002·Veterinary Immunology and Immunopathology·T J NuttallP B Hill
Dec 24, 2002·Proceedings. Biological Sciences·David C Krakauer, Akira Sasaki
Sep 12, 2007·Veterinary Dermatology·P B HillJ Rybnicek
Jan 19, 2008·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Akihiko HiyamaDaisuke Sakai
Jun 1, 2011·The British Journal of Dermatology·M OrcianiR Di Primio
Jun 19, 2013·Biochimie·Sahil K Kapur, Adam J Katz
Nov 16, 2013·Experimental & Molecular Medicine·Matthew B MurphyArnold I Caplan
Jan 28, 2014·Veterinary Dermatology·Thierry OlivryUNKNOWN International Committe on Allergic Diseases of Animals (ICADA)
Mar 25, 2014·Acta Veterinaria Scandinavica·Min Hee Kang, Hee Myung Park
Nov 27, 2014·World Journal of Stem Cells·Justin D Glenn, Katharine A Whartenby
Feb 17, 2015·Veterinary Dermatology·Domenico SantoroPetra Bizikova
Mar 25, 2015·BioMed Research International·Antonio J VillatoroJosé A Andrades
Mar 27, 2015·Veterinary Dermatology·Cherie M Pucheu-HastonMelissa N C Eisenschenk
Apr 29, 2015·World Journal of Stem Cells·Matthew W Klinker, Cheng-Hong Wei
Aug 9, 2015·Stem Cell Research & Therapy·Ozge Kizilay ManciniInés Colmegna
Nov 21, 2015·The Veterinary Journal·Manolis N Saridomichelakis, Thierry Olivry
Jan 13, 2016·Stem Cell Research & Therapy·Johannes Leibacher, Reinhard Henschler
Feb 24, 2016·Clinics in Dermatology·Cherie M Pucheu-Haston
Mar 12, 2016·Expert Review of Clinical Immunology·Lennart M RoesnerAnnice Heratizadeh
Mar 12, 2016·International Journal of Dermatology·Yingguo DingHong Fang
Jun 28, 2016·The Journal of Investigative Dermatology·Thierry OlivryJavier Cote-Sierra
Jan 27, 2017·International Journal of Molecular Sciences·Tae-Hoon ShinKyung-Sun Kang

❮ Previous
Next ❯

Citations

Dec 7, 2018·The Veterinary Record·Christoph Klinger
Mar 14, 2020·Acta Veterinaria Scandinavica·Nathaly EncisoConcepción Tejero
Jul 14, 2020·Frontiers in Veterinary Science·Metka VogaGregor Majdic
Jun 2, 2020·Frontiers in Cell and Developmental Biology·Sérgio Ricardo Teixeira DaltroMilena Botelho Pereira Soares

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.